Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Centrus Energy Corp (LEU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Centrus Energy Corp — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Centrus Energy Corp trades at $116.5 (market cap $2.45B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 3.6× Centrus Energy Corp's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Centrus Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Centrus Energy Corp for 31 Days on average.
| KYMR | LEU | |
|---|---|---|
Market Cap | $8.88B | $2.45B |
Volume | 1,028,790 | 1,447,414 |
Sector | Health | Energy |
52-Week High | $127.31 | $436.00 |
52-Week Low | $55.80 | $119.95 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $8.27B | $1.76B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Centrus Energy (LEU) trades at $134.28, down 0.76% on the day, with a bearish technical outlook despite recent earnings beats. The stock shows elevated valuation metrics with a P/E of 63.47 and P/S of 5.64, while profitability metrics remain solid with a 10.23% net income margin. Recent news highlights Centrus' strategic positioning as the only US-licensed producer of high-assay low-enriched uranium (HALEU), with multiple new supply contracts announced in September 2026.
The investment case hinges on execution of nuclear fuel contracts amid growing demand, but faces risks from high valuation and operational challenges. Analyst consensus remains positive with a $218.10 price target, though technical indicators suggest near-term pressure. The company's unique position in the nuclear supply chain offers growth potential, but requires careful monitoring of cash flow trends and contract execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →
